Ursodeoxycholic acid improves liver function and reduces serum and urinary endogenous bile acids in primary biliary cirrhosis. Hepatology 8(5): 1221, 1988
Effect of ursodeoxycholic acid treatment on plasma bile acids in Egyptian children with liver diseases. Gastroenterology 110(4 Suppl. ): A1231, 1996
Effects of ursodeoxycholic acid analogues of ursodeoxycholic acid and combination of bile acids on bile acid synthesis in cultured rat hepatocytes. Biochimica et Biophysica Acta 920(3): 195-204, 1987
Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. Journal of Hepatology 9(Suppl. 1): S61, 1989
Ursodeoxycholic acid reduces activin a release induced by hydrophobic bile acids in HepG2 cells. Journal of Hepatology 30(Suppl. 1): 93, 1999
Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts. Journal of Hepatology 29(5): 743-751, 1998
Use of ursodeoxycholic acids in a dog with chronic hepatitis: effects on serum hepatic tests and endogenous bile acid composition. Journal of Veterinary Internal Medicine 11(3): 195-197, 1997
Ursodeoxycholic acid reduces hepatic allograft rejection after orthotopic liver transplantation A prospective, randomized, placebo-controlled, double-blind trial. Hepatology 22(4 Part 2): 149A, 1995
Effects of ursodeoxycholic acid and colestilan versus ursodeoxycholic acid alone on serum bile acids and pruritus: A randomized, open-label study. Current Therapeutic Research 62(3): 221-229, 2001
Ursodeoxycholic acid udca reduces liver histologic alterations and portal hypertension induced by bile duct ligation in the rat. Journal of Hepatology 11(Suppl. 2): S50, 1990
Ursodeoxycholic acid induces significant changes of plasma bile acids in primary biliary cirrhosis. Journal of Hepatology 9(Suppl. 1): S231, 1989
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology 12(3 Pt 1): 492-497, 1990
Metabolisms of N-acetylglucosaminides bile acids during ursodeoxycholic acid treatment in patients with liver diseases. Gastroenterology 108(4 Suppl. ): A1097, 1995
Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease. European Journal of Gastroenterology and Hepatology 8(5): 477-483, 1996